228 related articles for article (PubMed ID: 31015171)
1. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
4. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
5. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.
Skipar K; Hompland T; Lund KV; Løndalen A; Malinen E; Kristensen GB; Lindemann K; Nakken ES; Bruheim K; Lyng H
Radiother Oncol; 2022 Nov; 176():17-24. PubMed ID: 36113778
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
Gu KW; Kim CK; Choi CH; Yoon YC; Park W
Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
[TBL] [Abstract][Full Text] [Related]
10. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
12. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
14. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
Zhao B; Cao K; Li XT; Zhu HT; Sun YS
BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.
Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK
Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of diffusion-weighted magnetic resonance imaging and
Park JJ; Kim CK; Park BK
Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
[TBL] [Abstract][Full Text] [Related]
17. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.
Brandmaier P; Purz S; Bremicker K; Höckel M; Barthel H; Kluge R; Kahn T; Sabri O; Stumpp P
PLoS One; 2015; 10(11):e0141684. PubMed ID: 26551527
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
